FMC

FMC's first global dossier for rimisoxafen seeks U.S. approval for a dual-action herbicide aimed at tough broadleaf weeds in major crops.

The submission marks an important milestone in FMC's efforts to advance next-generation weed control technologies as resistance pressure intensifies in key row crop markets. PHILADELPHIA, July 8, 2026 /PRNewswire/ -- FMC Corporation (NYSE: FMC), a leading global agricultural sciences company, today announced it has submitted the regulatory dossier for rimisoxafen to the United States (U.S.) Environmental Protection Agency (EPA), the first regulatory submission globally for this groundbreaking herbicide active ingredient.

FMC secures a $400 million investment from Tessenderlo Group to cut debt, strengthen liquidity and support crop protection technology growth.

Tessenderlo Group's investment reflects its strategy of making cornerstone minority investments in high-quality companies Investment enables FMC to achieve approximately $1 billion debt paydown target FMC concludes strategic options review FMC maintains focus on delivering on its operational and strategic plan PHILADELPHIA and BRUSSELS, June 30, 2026 /PRNewswire/ -- FMC Corporation (NYSE: FMC), a leading global agricultural sciences company, and Tessenderlo Group (XBRU: TESB), a Belgian-based industrial group, today announced that they have entered into a definitive agreement under which Tessenderlo Group will make a strategic minority equity investment in FMC Corporation of approximately $400 million USD at a price of $13.30 per share. Upon completion of the transaction, Tessenderlo Group will own approximately 20.0% of the outstanding shares of FMC common stock.

FMC plans a $114M Newark property sale to cut debt, retain key R&D operations and keep its Stine Research Center fully intact.

Company will continue to operate its global R&D headquarters at the Stine Research Center PHILADELPHIA, June 23, 2026 /PRNewswire/ -- FMC Corporation (NYSE: FMC), a leading global agricultural sciences company, today announced that it has entered into a framework agreement to sell its property in Newark, Delaware for gross proceeds of approximately $114 million USD, subject to a due diligence period and other closing conditions and adjustments. Upon completion of the sale, FMC intends to lease back the facilities it actively operates under a separate lease agreement.

PHILADELPHIA, June 22, 2026 /PRNewswire/ -- FMC Corporation (NYSE: FMC) announced today it will release its second quarter 2026 earnings on Wednesday, July 29, 2026, after the stock market close via PR Newswire and the company's website https://investors.fmc.com. The company will host a webcast conference call on Thursday, July 30, 2026, at 9:00 a.m.

FMC's rimisoxafen deal with Corteva aims to expand access to dual-mode herbicide technology for corn and soybean markets across the Americas.

FMC Corporation (FMC) Presents at 3rd Annual Materials of the Future Conference Transcript

Strategic supply and license agreement will accelerate access for North and South American corn and soybean growers PHILADELPHIA and INDIANAPOLIS, June 16, 2026 /PRNewswire/ -- FMC Corporation (NYSE: FMC) and Corteva, Inc. (NYSE: CTVA), two leading global agricultural science and innovation companies, today announced a co-exclusive strategic supply and license agreement that will expand access to FMC's rimisoxafen technology across North and South America corn and soybean markets, adding an important new tool to each company's respective herbicide portfolio. This collaboration will enable more growers across the Americas to control herbicide-resistant weeds, including Amaranthus species – the number one weed resistance challenge globally in soybeans and critical in cross-crop pressure in corn – with this groundbreaking dual mode of action herbicide technology.